We are live on
!
Find out more
PVI
Pura Vida Investments Portfolio holdings
AUM
$14.9M
1-Year Est. Return
38.76%
This Fund
S&P 500
This Quarter
Est. Return
-6.42%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$3.29B
AUM Growth
+$73M
(+2.3%)
Cap. Flow
+$288M
Cap. Flow
% of AUM
8.77%
Top 10 Holdings %
Top 10 Hldgs %
33.54%
Holding
352
New
136
Increased
52
Reduced
76
Closed
78
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
LivaNova
LIVN
|
+$42.5M |
| 2 |
MAPS
WM TECHNOLOGY INC A
MAPS
|
+$23.3M |
| 3 |
Seer Inc
SEER
|
+$20.8M |
| 4 |
Glaukos
GKOS
|
+$17.9M |
| 5 |
Cooper Companies
COO
|
+$17.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
INOV
Inovalon Holdings, Inc. Class A Common Stock
INOV
|
+$60.7M |
| 2 |
Intellia Therapeutics
NTLA
|
+$26.2M |
| 3 |
Organogenesis Holdings
ORGO
|
+$19.9M |
| 4 |
Eli Lilly
LLY
|
+$15.1M |
| 5 |
CMIIU
CM Life Sciences II Inc. Unit
CMIIU
|
+$14.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 33.25% |
| 2 | Consumer Staples | 0.8% |
| 3 | Technology | 0.71% |
| 4 | Industrials | 0.71% |
| 5 | Materials | 0.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Schrodinger
SDGR
$1.39B
| $6.63M | 0.2% |
121,231
-56,868
| -32% | -$3.64M |
|
|
RCM
127
DELISTED
R1 RCM Inc. Common Stock
RCM
| $6.6M | 0.2% |
300,000
-659,522
| -69% | -$13.6M |
|
|
NYXH
128
Nyxoah
NYXH
$158M
| $6.54M | 0.2% |
+225,214
| New | +$7.13M |
|
129
Merck
MRK
$328B
| $6.38M | 0.19% |
+85,000
| New | +$6.46M |
|
|
IMGN
130
CALL
DELISTED
Immunogen Inc
IMGN
| $6.22M | 0.19% |
1,097,500
+609,800
| +125% | +$3.52M |
|
131
Rapid Micro Biosystems
RPID
$84.8M
| $6.13M | 0.19% |
+332,136
| New | +$6.86M |
|
132
Procept Biorobotics
PRCT
$1.22B
| $6.1M | 0.19% |
+160,000
| New | +$6.14M |
|
133
Bioventus
BVS
$1.17B
| $6.08M | 0.18% |
429,129
-115,416
| -21% | -$1.78M |
|
134
CALL
Nektar Therapeutics
NKTR
$2.57B
| $6.06M | 0.18% |
+22,507
| New | +$5.41M |
|
135
CALL
Quanterix
QTRX
$139M
| $5.97M | 0.18% |
120,000
+20,000
| +20% | +$1.03M |
|
|
ARNA
136
PUT
DELISTED
Arena Pharmaceuticals Inc
ARNA
| $5.96M | 0.18% |
+100,000
| New | +$5.91M |
|
137
908 Devices
MASS
$414M
| $5.88M | 0.18% |
180,888
+19,829
| +12% | +$674K |
|
138
PUT
Thermo Fisher Scientific
TMO
$223B
| $5.71M | 0.17% |
10,000
-35,000
| -78% | -$19.2M |
|
|
139
Intellia Therapeutics
NTLA
$1.69B
| $5.64M | 0.17% |
42,059
-172,841
| -80% | -$26.2M |
|
|
MSON
140
DELISTED
Misonix Inc
MSON
| $5.52M | 0.17% |
218,100
-254,116
| -54% | -$6.29M |
|
141
Vertex Pharmaceuticals
VRTX
$133B
| $5.44M | 0.17% |
+30,000
| New | +$5.86M |
|
|
IVC
142
DELISTED
Invacare Corporation
IVC
| $5.41M | 0.16% |
1,137,028
-223,927
| -16% | -$1.64M |
|
|
ARYD
143
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $5.29M | 0.16% |
526,217
-8,962
| -2% | -$90.5K |
|
|
CCXI
144
PUT
DELISTED
ChemoCentryx, Inc.
CCXI
| $5.13M | 0.16% |
+300,000
| New | +$4.67M |
|
|
RACB
145
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $5.04M | 0.15% |
511,480
-8,700
| -2% | -$86.1K |
|
146
CALL
Haemonetics
HAE
$4.16B
| $4.94M | 0.15% |
+70,000
| New | +$4.42M |
|
|
LYRA
147
DELISTED
LYRA THERAPEUTICS INC
LYRA
| $4.87M | 0.15% |
10,668
-185
| -2% | -$70K |
|
148
Milestone Pharmaceuticals
MIST
$141M
| $4.86M | 0.15% |
850,312
+147,767
| +21% | +$833K |
|
|
ACH
149
PUT
Accendra Health
ACH
$93.1M
| $4.69M | 0.14% |
+150,000
| New | +$5.9M |
|
150
Avita Medical
RCEL
$251M
| $4.47M | 0.14% |
252,246
-6,705
| -3% | -$127K |
|
Similar funds
BCA
RC
DOFI
SCI
LPC
GBCP
SCTC
M
Pura Vida Investments's Q3 2021 Portfolio in Review
As of Q3 2021, Pura Vida Investments held 352 positions worth $3.29B, up 2.3% from $3.21B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Pura Vida Investments deployed $288M of net new capital in Q3 2021, opening 136 new positions and adding to 52 existing holdings. Its largest new stake was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, down from 35% a quarter earlier, followed by Consumer Staples and Technology.
On the sell side, the largest reduction was Intellia Therapeutics, an estimated $26.2M trimmed.
- Pura Vida Investments's largest Q3 2021 buy was WM TECHNOLOGY INC A: 1,612,498 shares worth $23.4M.
- Pura Vida Investments added most to LivaNova in Q3 2021, an estimated $42.5M increase.
- Pura Vida Investments's biggest Q3 2021 reduction was Intellia Therapeutics, cutting an estimated $26.2M.
- Pura Vida Investments fully exited Inovalon Holdings, Inc. Class A Common Stock in Q3 2021, selling an estimated $60.7M.
- Pura Vida Investments's ten largest holdings make up 34% of its $3.29B portfolio in Q3 2021.
- Pura Vida Investments opened 136 new positions and closed 78 in Q3 2021.
- Pura Vida Investments's portfolio value rose 2.3% quarter-over-quarter to $3.29B.
Based on Pura Vida Investments's 13F filing for Q3 2021, filed 15 Nov 2021.